Tylenol and Autism: Evidence, Scientific Blunders, and Medicine Gone Wrong

Conclusion: Many Cases of Autism Due to Postnatal Acetaminophen Usage

In this book, Dr. Parker focuses on the growing body of peer-reviewed scientific evidence (see Sources & References, below) that suggests a strong association between acetaminophen exposure (particularly around labor, delivery, and early childhood) and the risk of developing autism spectrum disorder in susceptible children, especially boys. He follows 30 different lines of evidence from different fields to corroborate this association. The book includes a full discussion of each of these lines of evidence as well as a summary table at the back of the book (for a handy reference guide). His conclusion is below:

The 30 lines of inquiry are divided into sections including:

• Pharmacologic evidence (6 lines)
• Associations involving time, place, or human behavior (12 lines)
• Laboratory animal studies (4 lines)
• Miscellaneous evidence (8 lines)

Some of the more compelling lines of evidence (to this reader, at least) are as follows.

Mechanisms of Toxicity and Susceptibility

In the book, Dr. Parker discusses the metabolic pathways and susceptibilities that influence how acetaminophen (often denoted by its chemical abbreviation APAP in the book) affects the brain, particularly in newborns and young children. Children with autism often have compromised pathways (such as the glucuronidation, sulfation, and cytochrome P450 oxidation pathways) for safely metabolizing acetaminophen, making them more vulnerable to its toxic intermediates. Glucuronidation isn’t functional until about two months of age and isn’t fully mature until about two years of age, leaving the youngest children highly vulnerable to Tylenol’s toxic effects. (Reminder here that children are not just adults in small bodies.) Children that cannot detoxify acetaminophen through these pathways produce a toxic byproduct known as NAPQI (N-acetyl-p-benzoquinone imine).

The Role of Oxidative Stress

Dr. Parker’s paper “The Role of Oxidative Stress, Inflammation and Acetaminophen Exposure from Birth to Early Childhood in the Induction of Autism“, discussed in the book, explored the role of oxidative stress as a common denominator in factors associated with autism. Oxidative stress depletes glutathione, which is necessary for detoxifying acetaminophen. Too much oxidative stress impairs the body’s ability to neutralize acetaminophen’s toxic byproducts and increases vulnerability to drug-induced neurodevelopmental damage, especially when combined with infections, common well-baby-visit medications, or other environmental exposures. Children with certain immune/metabolic vulnerabilities are both more prone to oxidative stress and less able to detoxify NAPQI, leaving them more susceptible to neurodevelopmental damage from Tylenol.

Time, Place or Human Behavior Associations

Dr. Parker explores the historical and geographic rise in autism rates in parallel with increases in acetaminophen use, policy changes, and drug marketing. He discusses spikes in autism cases following the switch from aspirin to Tylenol for children after the American Academy of Pediatrics issued guidelines in 1982 advising against the use of aspirin in children with viral illnesses because of the link between aspirin and Reye’s syndrome, which can potentially be fatal.

The first study that suggested that acetaminophen exposure in susceptible children might trigger autism was headed by Steven Schultz and published in 2008. It showed that if parents gave acetaminophen to their children between 12 and 18 months of age, the child had a 20 times greater likelihood of regression into autism.

He also digs into variations in autism rates that correspond to differences in acetaminophen use across regions or populations. One such compelling study compared the popularity of acetaminophen use and the prevalence of autism between Denmark and Finland. Denmark has a much higher use of acetaminophen and also has a higher rate of autism than Finland. While such an analysis does not prove causality, it does add to the total body of evidence.

Another example of geographic evidence is the case of Cuba, in which acetaminophen is available by prescription only. The rate of autism in Cuba is only 1 in 25,000, compared to 1 in 22 children in the United States (data published in Pediatrics, 2026). William Shaw PhD also used Cuba’s low autism rate and low acetaminophen usage in his 2015 video, Increased Acetaminophen Use Appears to Be Major Cause of the Epidemics of Autism.

Surprising Conclusion: Postnatal Usage Is More Harmful Than Prenatal Usage

Despite pronouncements from the Trump administration in 2025 saying that pregnant mothers should not take Tylenol, Dr. Parker shows plenty of evidence that it’s the Tylenol given to children up to the age of six years that does more neurodevelopmental harm than prenatal usage. The reason for this is that a fetus is somewhat protected by the mother’s liver.

Surprising Fact: Tylenol Has Never Been Tested for Neurodevelopmental Safety

While working at Duke University as a biochemical researcher, Dr. Parker co-authored “Paracetamol (Acetaminophen) Use in Infants and Children Was Never Shown to Be Safe for Neurodevelopment: A Systematic Review with Citation Tracking.” He and his fellow co-authors realized after tracking previous studies about acetaminophen that the thought that “Tylenol is safe” is based on opinion, not on evidence. In fact, the authors concluded that:

Scientific Errors

Parker asserts that “the big problem preventing most great scientists of our day from seeing a connection between acetaminophen and autism” is that “when it comes to acetaminophen, (scientists) have assumed that interacting varaiable are confounding factors.” He walks the reader through examples of how to understand this as well as examples of research papers that have made this error. “Scientists have missed the big picture and failed to recognize that (acetaminophen) interacts with oxidative stress to cause autism.” He notes that this error involves a lack of knowledge of pharmacology as well as statistical knowledge so that “the resulting math… is essentially answering the wrong question.” Thus, scientists who have made this error show that “standard statistical analyses find that the reason for giving the acetaminophen (such as a child being sick), or other factors related to oxidative stress, not the acetaminophen itself, is causing autism.”

According to Parker, the most egregious example of this error was made by a group at Drexel University in 2024 in the Journal of the American Medical Association (JAMA). “The paper confused confounding variables with interacting factors, erroneously concluded that no legitimate association between acetaminophen and autism exists” because “they essentially took sickness and oxidative stress out of the equation in all of their analyses.” Parker and his colleagues quickly covered the error in a publication. A 2025 Harvard paper correctly concluded that acetaminophen given to pregnant mothers could lead to neurodevelopmental disorders in their children, but ignored the error entirely.

“Oops, That Was Wrong” Scientific Blunders

In the book, Parker walks us through rebuttals of common errors in scientific thinking such as:

• “Acetaminophen has been used for so long and is used so much that if it really caused autism, we’d see autism universally by now.
• Correlation doesn’t equal causation, so therefore you can’t say acetaminophen causes autism.
• Blaming autism on one factor is oversimplifying a complex issue. A simple chemical alonge can’t explain something as multifactorial as autism.
• Studies in laboratory animals are not reliable and should not be used as a basis for any conclusions.
• Studies in siblings and twins prove that autism is genetic, so acetaminophen can’t cause autism.
• Fevers are associated with autism; therefore, fevers must be blocked.
• My child was never exposed to acetaminophen, and has autism; so acetaminophen doesn’t cause autism.”

Conclusion

Parker provides ample and compelling evidence to dissuade pregnant mothers and parents from using acetaminophen for their children. While the preponderance of evidence points to a likely causative role in the etiology of autism, we cannot wait for scientists to settle this argument among themselves so that they can finally say that acetaminophen is unsafe for pregnant mothers and young children. Instead, we recommend that parents read this book and then use the precautionary principle. We also recommend that parents consult with their healthcare practitioners in looking for alternatives to acetaminophen. If your child’s doctor is open to examining the evidence, we highly recommend that they read this book.

About William Parker Phd

Still Looking for Answers?

Visit the Documenting Hope Practitioner Directory to find a practitioner near you.

Join us inside our online membership community for parents, Healing Together, where you’ll find even more healing resources, expert guidance, and a community to support you every step of your child’s healing journey.

More To Explore